The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 19, 2026
Filed:
May. 20, 2020
Applicant:
Tyk Medicines, Inc., Huzhou, CN;
Inventors:
Jun Li, Huzhou, CN;
Maolin Zheng, Huzhou, CN;
Chengshan Niu, Huzhou, CN;
Apeng Liang, Huzhou, CN;
Yusheng Wu, Huzhou, CN;
Assignee:
TYK MEDICINES, INC., Huzhou, CN;
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/444 (2006.01); A61K 31/4355 (2006.01); A61K 31/437 (2006.01); A61K 31/4725 (2006.01); A61K 31/497 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 31/519 (2006.01);
U.S. Cl.
CPC ...
A61K 31/444 (2013.01); A61K 31/4355 (2013.01); A61K 31/437 (2013.01); A61K 31/4725 (2013.01); A61K 31/497 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01);
Abstract
The present invention belongs to the field of medical technology and specifically disclosed is a compound represented by formula (I′), or a pharmaceutically acceptable salt, stereoisomer, solvate or prodrug thereof, and each symbol therein is as defined in the claims. The compound of the present invention may be used as a drug for regulating RET kinase activity or treating RET-related diseases, and has better pharmacokinetic properties.